Kensico Capital Management Corp acquired a new position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 611,000 shares of the company’s stock, valued at approximately $34,436,000. Ryan Specialty accounts for about 0.5% of Kensico Capital Management Corp’s holdings, making the stock its 20th biggest position.
Several other large investors also recently made changes to their positions in the business. Ameritas Investment Partners Inc. raised its stake in shares of Ryan Specialty by 0.9% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 21,119 shares of the company’s stock valued at $1,190,000 after acquiring an additional 185 shares during the period. MAI Capital Management increased its position in shares of Ryan Specialty by 65.3% in the 2nd quarter. MAI Capital Management now owns 476 shares of the company’s stock worth $32,000 after purchasing an additional 188 shares during the last quarter. Baker Tilly Wealth Management LLC raised its stake in shares of Ryan Specialty by 5.6% in the 3rd quarter. Baker Tilly Wealth Management LLC now owns 3,595 shares of the company’s stock valued at $203,000 after purchasing an additional 192 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Ryan Specialty by 5.2% in the 2nd quarter. ProShare Advisors LLC now owns 4,772 shares of the company’s stock valued at $324,000 after purchasing an additional 238 shares in the last quarter. Finally, Securian Asset Management Inc. lifted its position in shares of Ryan Specialty by 2.9% during the third quarter. Securian Asset Management Inc. now owns 8,438 shares of the company’s stock worth $476,000 after purchasing an additional 241 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.
Insider Activity at Ryan Specialty
In other Ryan Specialty news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the business’s stock in a transaction dated Monday, February 23rd. The shares were bought at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director owned 428,295 shares in the company, valued at approximately $17,114,668.20. This represents a 6.33% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 52.21% of the company’s stock.
Ryan Specialty Stock Performance
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings data on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The firm had revenue of $751.21 million during the quarter, compared to analyst estimates of $777.43 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The firm’s revenue was up 13.2% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. On average, research analysts predict that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.
Ryan Specialty Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 24th were given a $0.13 dividend. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date was Tuesday, February 24th. This represents a $0.52 annualized dividend and a yield of 1.4%. Ryan Specialty’s payout ratio is currently 123.81%.
Analyst Upgrades and Downgrades
A number of research firms recently commented on RYAN. Cantor Fitzgerald decreased their price target on Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating for the company in a research note on Tuesday, February 17th. TD Cowen restated a “buy” rating on shares of Ryan Specialty in a research note on Wednesday, November 26th. Keefe, Bruyette & Woods decreased their target price on Ryan Specialty from $65.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, February 13th. Barclays lowered their price target on Ryan Specialty from $52.00 to $45.00 and set an “overweight” rating for the company in a report on Wednesday, March 11th. Finally, JPMorgan Chase & Co. dropped their price target on Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating on the stock in a research report on Wednesday, January 7th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $56.40.
View Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Company Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Further Reading
- Five stocks we like better than Ryan Specialty
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
